As global conversations on climate change and environmental sustainability gain momentum, industries across the spectrum are reevaluating their practices to minimize ecological impact. The pharmaceutical sector, often scrutinized for its resource-intensive processes, is witnessing a shift towards sustainability. Farmson Pharmaceuticals, a trailblazer in the pharmaceutical industry, stands out for its steadfast commitment to environmental responsibility. This blog delves into Farmson’s sustainable practices, highlighting their initiatives aimed at reducing the industry’s ecological footprint. Read more: https://www.farmson.com/blogs/striking-a-green-balance-farmson-pharmaceuticals-commitment-to-environmental-responsibility/
Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Subscribe to:
Post Comments (Atom)
Research & Development - Driving Innovation at Farmson
Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic ca...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...

No comments:
Post a Comment